Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Healthtrust
Merck
Chubb
Argus Health
Cerilliant
Fuji
US Department of Justice
Julphar

Generated: April 26, 2018

DrugPatentWatch Database Preview

NADOLOL AND BENDROFLUMETHIAZIDE Drug Profile

« Back to Dashboard

When do Nadolol And Bendroflumethiazide patents expire, and what generic alternatives are available?

Nadolol And Bendroflumethiazide is a drug marketed by Impax Labs and Mylan and is included in two NDAs.

The generic ingredient in NADOLOL AND BENDROFLUMETHIAZIDE is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.
Drug patent expirations by year for NADOLOL AND BENDROFLUMETHIAZIDE
Pharmacology for NADOLOL AND BENDROFLUMETHIAZIDE
Synonyms for NADOLOL AND BENDROFLUMETHIAZIDE
Bendroflumethiazide mixture with nadolol
BENDROFLUMETHIAZIDE; NADOLOL
C17H27NO4.C15H14F3N3O4S2
D153992480
LS-178520
Nadolol and bendroflumethazide
Nadolol/Bendroflumethiazide
SCHEMBL4066540

US Patents and Regulatory Information for NADOLOL AND BENDROFLUMETHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs NADOLOL AND BENDROFLUMETHIAZIDE bendroflumethiazide; nadolol TABLET;ORAL 077833-001 Mar 30, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NADOLOL AND BENDROFLUMETHIAZIDE bendroflumethiazide; nadolol TABLET;ORAL 078688-002 Feb 15, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs NADOLOL AND BENDROFLUMETHIAZIDE bendroflumethiazide; nadolol TABLET;ORAL 077833-002 Mar 30, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NADOLOL AND BENDROFLUMETHIAZIDE bendroflumethiazide; nadolol TABLET;ORAL 078688-001 Feb 15, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Medtronic
Express Scripts
US Department of Justice
Moodys
Chinese Patent Office
Chubb
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.